Apogee Therapeutics APGE
APGE
$135.07 +1.11 (+0.83%)
At close: Sep 2, 2026 · 4:00 PM EDT

Apogee Therapeutics (APGE) Liabilities and Shareholders Equity (2022 - 2026)

Updated

Apogee Therapeutics (APGE) reported Liabilities and Shareholders Equity of $1.34 billion for Q2 2026, up 103.1% from $657.77 million a year earlier and up 3.3% from the prior quarter.

Analysis

Apogee Therapeutics (APGE) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends

At the end of FY2025, Apogee Therapeutics posted Liabilities and Shareholders Equity of $937.13 million, up 24.3% from FY2024.

  • Liabilities and Shareholders Equity has increased for three consecutive years, with a three-year compound annual growth rate of 83.3% (FY2022 to FY2025).
  • By year, Liabilities and Shareholders Equity came in at $753.95 million in FY2024 (+87.8%), $401.4 million in FY2023 (+164.0%) and $152.06 million in FY2022.
  • The Q2 2026 figure ranks as the highest quarterly Liabilities and Shareholders Equity in data going back to Q4 2022.
  • Year over year, Liabilities and Shareholders Equity has now increased in each of the last three quarters, with growth averaging 41.0% over the last eight quarters.
  • The high point for year-over-year Liabilities and Shareholders Equity in five years was Q2 2024 (growth of 512.7%); the low point was Q3 2025 (a decline of 19.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.29 billion (Q1 2026), $937.13 million (Q4 2025) and $626.16 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Apogee Therapeutics 10.18 Bn 7.68 Bn - 1.34 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.34 Bn
Mar 31, 2026 1.29 Bn
Dec 31, 2025 937.13 Mn
Sep 30, 2025 626.16 Mn
Jun 30, 2025 657.77 Mn
Mar 31, 2025 714.16 Mn
Dec 31, 2024 753.95 Mn
Sep 30, 2024 776.29 Mn
Jun 30, 2024 800.66 Mn
Mar 31, 2024 823.66 Mn
Dec 31, 2023 401.40 Mn
Sep 30, 2023 426.42 Mn
Jun 30, 2023 130.67 Mn
Dec 31, 2022 152.06 Mn
API Access

Apogee Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=APGE&period=max&api_key=YOUR_API_KEY